Anlon Healthcare Limited has announced the incorporation of its wholly-owned subsidiary, "ANLON MEDICARE PRIVATE LIMITED" (CIN: U21006GJ2026PTC180329), effective July 09, 2026. This strategic move aligns with the company's long-term growth objectives. The newly incorporated subsidiary will focus on manufacturing surgical implants and medical devices. Anlon Healthcare intends to leverage this opportunity to strategically complement and expand its existing business within the pain management segment, capitalizing on the significant growth potential in this sector both in India and internationally. The subsidiary has been incorporated with an authorized share capital of ₹5,000,000 and a paid-up share capital of ₹2,000,000. Anlon Healthcare Limited has subscribed to 1,10,000 equity shares of face value ₹10 each, amounting to ₹1,100,000, thereby holding a 55% stake in the subsidiary. The company has confirmed that the subscription to the share capital is by way of cash through banking channels and is not a related party transaction.
